Microbiotica raises EUR42M Series C+ backed by British Business Bank, Cambridge Innovation Capital and others
The funding round closed on October 1, 2026, with participation from British Business Bank, Cambridge Innovation Capital, Flerie Invest, IP Group, Seventure Partners, and Tencent. Total capital raised by Microbiotica now stands at EUR64.7M.
Based in the United Kingdom, the company develops microbiome precision medicine using a proprietary platform that analyzes clinical datasets and bacterial signatures. The startup is at the Series B stage and was co-founded by Dr. Alexandra Laborda and Dr. Anthony Prevost.
In the UK healthcare and life sciences category, Brouky tracks 353 deals over the past 12 months with a median amount of EUR7.0M.
Related insights
- Deal SpotlightRivercell raises EUR22.4M Seed backed by Alven
- Deal SpotlightBridgesmile raises EUR49.959M Series A backed by 11 investors
- Deal SpotlightHeadline raises EUR30.42M Seed backed by British Business Bank
- Deal SpotlightDailyObjects raises EUR36.52M Series C+ backed by 360 One Asset Management, Anicut Capital, Axiom Asia Private Capital, Roots Ventures, Trifecta Capital
Explore the full dataset
Brouky tracks 37,000+ investors and 122,000+ investments across 134,000+ startups. Search by country, stage, and sector.